03:36 PM EST - DiaMedica Inc. : Announced that the U.S. Patent and Trademark Office has issued U.S. Patent No. 9364521, entitled "Human Tissue Kallikrein 1 Glycosylation Isoforms". This patent contains claims that cover the composition of matter of DiaMedica's product candidate, DM199, and pharmaceutical compositions comprising DM199. DiaMedica Inc.
shares V.DMA are trading up $0.005 at $0.21.
